" class="no-js "lang="en-US"> Roy Smythe - Medtech Alert
Sunday, May 18, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Roy Smythe

Roy Smythe

About Roy Smythe

executive • physician • strategist • entrepreneur • biomedical scientist • humanitarian • dad • amateur artist • Homo Sapiens

Related Story

Industry News

 Somalogic Acquires DNA Nanotechnology Leader Palamedrix to Develop the Next-generation SomaScan® Assay | Pharmtech Focus

Somalogic Acquires DNA Nanotechnology Leader Palamedrix to Develop the Next-generation SomaScan® Assay

July 27 2022

SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced it entered into […]

Appointments

 SomaLogic Announces Appointment of Adam Taich as Chief Business Officer | Pharmtech Focus

SomaLogic Announces Appointment of Adam Taich as Chief Business Officer

January 11 2022

SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that Adam Taich has […]

Industry News

 SomaLogic Announces Exclusive Partnership with Illumina to Develop Sequencing-based Proteomic Solutions | Pharmtech Focus

SomaLogic Announces Exclusive Partnership with Illumina to Develop Sequencing-based Proteomic Solutions

January 6 2022

SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a worldwide strategic collaboration […]

Clinical Trials

 SomaLogic Announces Strategic Collaboration with University Hospitals Cleveland Medical Center to Treat Diabetic Patients at High Risk of Cardiovascular Disease | Pharmtech Focus

SomaLogic Announces Strategic Collaboration with University Hospitals Cleveland Medical Center to Treat Diabetic Patients at High Risk of Cardiovascular Disease

November 1 2021

SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a strategic collaboration with […]

Appointments

 SomaLogic Announces Appointment of Shaun Blakeman as Chief Financial Officer | Pharmtech Focus

SomaLogic Announces Appointment of Shaun Blakeman as Chief Financial Officer

August 3 2021

CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a leader in AI-data driven proteomics technology, […]